Cargando…
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
BACKGROUND: The mechanisms behind residual platelet reactivity (RPR) despite aspirin treatment are not established. It has been shown that coronary artery disease (CAD) patients with high on-aspirin RPR have elevated levels of von Willebrand factor (vWF). ADAMTS13 is a metalloprotease cleaving ultra...
Autores principales: | Warlo, Ellen M. K., Pettersen, Alf-Åge R., Arnesen, Harald, Seljeflot, Ingebjørg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700557/ https://www.ncbi.nlm.nih.gov/pubmed/29200971 http://dx.doi.org/10.1186/s12959-017-0151-3 |
Ejemplares similares
-
Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial
Fibrillation and Cerebral Ischemic Events
por: Warlo, Ellen M. K., et al.
Publicado: (2022) -
High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)
por: Pettersen, Alf-Åge R., et al.
Publicado: (2012) -
Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
por: Bratseth, Vibeke, et al.
Publicado: (2012) -
A brief review on resistance to P2Y(12) receptor antagonism in coronary artery disease
por: Warlo, Ellen M. K., et al.
Publicado: (2019) -
Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
por: Opstad, Trine B, et al.
Publicado: (2010)